The orthobiologics market in North America is estimated to grow to around $4796.3 million by 2018


Posted September 30, 2014 by tonypandrew

The North American orthobiologics report defines and segments the concerned market in North America with analysis and forecast of revenue.

 
The North American orthobiologics report defines and segments the concerned market in North America with analysis and forecast of revenue. The orthobiologics market in North America is estimated to grow to around $4796.3 million by 2018, at a developing CAGR of 7.2% from 2013 to 2018.
Browse through the TOC of the North American orthobiologics market, to get an idea of the in-depth analysis provided. This also provides glimpse of orthobiologics market segmentation in the same region, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/north-america-orthobiologics-9077664565.html

The major factors for the growth of orthopedics market in North America are reimbursement policies for orthopedic treatment, increased affordability, and higher adoption of upcoming technologies such as MIS and orthobiologics solution.
The population aging is high in North America and 14% of the total North American population is above 65 years of age. The number of the older population is expected to increase manifold in future. They are prone to osteoarthritis and bone fracture and require orthopedic treatments and implants on a large scale. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and sport injuries has augmented the growth of this market.
The U.S. contributes largely to the orthobiologics market in North America, with around 92% alone, in 2014. In addition to rising number of aging population, U.S. also has highest incidence rates of osteoporosis, which is one of the causes of bone fracture amongst the elderly.
This market is segmented and forecast on the basis of various types of products, namely, bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation. The market is further segmented and forecast on the basis of major countries, such as the U.S., Canada and Mexico. The market is also segmented and analyzed further on the basis of the end users.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By micromarketmonitor
Country United States
Categories Health
Tags north american orthobiologics market
Last Updated September 30, 2014